219 related articles for article (PubMed ID: 18793854)
1. Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.
Byun JH; Kim H; Kim Y; Mook-Jung I; Kim DJ; Lee WK; Yoo KH
Bioorg Med Chem Lett; 2008 Oct; 18(20):5591-3. PubMed ID: 18793854
[TBL] [Abstract][Full Text] [Related]
2. Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation.
Byeon SR; Lee JH; Sohn JH; Kim DC; Shin KJ; Yoo KH; Mook-Jung I; Lee WK; Kim DJ
Bioorg Med Chem Lett; 2007 Mar; 17(5):1466-70. PubMed ID: 17270435
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.
Ouberai M; Dumy P; Chierici S; Garcia J
Bioconjug Chem; 2009 Nov; 20(11):2123-32. PubMed ID: 19821579
[TBL] [Abstract][Full Text] [Related]
4. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
[TBL] [Abstract][Full Text] [Related]
5. Linear quantitation of Abeta aggregation using Thioflavin T: reduction in fibril formation by colostrinin.
Bourhim M; Kruzel M; Srikrishnan T; Nicotera T
J Neurosci Methods; 2007 Mar; 160(2):264-8. PubMed ID: 17049613
[TBL] [Abstract][Full Text] [Related]
6. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
7. Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling.
Zheng M; Zheng M; Ye D; Deng Y; Qiu S; Luo X; Chen K; Liu H; Jiang H
Bioorg Med Chem Lett; 2007 May; 17(9):2414-20. PubMed ID: 17336065
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
Chen SY; Chen Y; Li YP; Chen SH; Tan JH; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Sep; 19(18):5596-604. PubMed ID: 21840724
[TBL] [Abstract][Full Text] [Related]
9. Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity.
Rizzo S; Rivière C; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Morroni F; Tarozzi A; Monti JP; Rampa A
J Med Chem; 2008 May; 51(10):2883-6. PubMed ID: 18419109
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of indane-2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as beta-amyloid aggregation inhibitors.
Catto M; Aliano R; Carotti A; Cellamare S; Palluotto F; Purgatorio R; De Stradis A; Campagna F
Eur J Med Chem; 2010 Apr; 45(4):1359-66. PubMed ID: 20137834
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.
Howlett DR; Perry AE; Godfrey F; Swatton JE; Jennings KH; Spitzfaden C; Wadsworth H; Wood SJ; Markwell RE
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):283-9. PubMed ID: 10229684
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K
Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and exploration of novel curcumin analogues as anti-malarial agents.
Mishra S; Karmodiya K; Surolia N; Surolia A
Bioorg Med Chem; 2008 Mar; 16(6):2894-902. PubMed ID: 18194869
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
[TBL] [Abstract][Full Text] [Related]
16. Designed amyloid beta peptide fibril - a tool for high-throughput screening of fibril inhibitors.
Dolphin GT; Ouberai M; Dumy P; Garcia J
ChemMedChem; 2007 Nov; 2(11):1613-23. PubMed ID: 17876751
[TBL] [Abstract][Full Text] [Related]
17. Structural optimization and biological evaluation of substituted bisphenol A derivatives as beta-amyloid peptide aggregation inhibitors.
Zhou Y; Jiang C; Zhang Y; Liang Z; Liu W; Wang L; Luo C; Zhong T; Sun Y; Zhao L; Xie X; Jiang H; Zhou N; Liu D; Liu H
J Med Chem; 2010 Aug; 53(15):5449-66. PubMed ID: 20684593
[TBL] [Abstract][Full Text] [Related]
18. Catechol derivatives inhibit the fibril formation of amyloid-beta peptides.
Huong VT; Shimanouchi T; Shimauchi N; Yagi H; Umakoshi H; Goto Y; Kuboi R
J Biosci Bioeng; 2010 Jun; 109(6):629-34. PubMed ID: 20471605
[TBL] [Abstract][Full Text] [Related]
19. Chitooligosaccharides suppress the level of protein expression and acetylcholinesterase activity induced by Abeta25-35 in PC12 cells.
Lee SH; Park JS; Kim SK; Ahn CB; Je JY
Bioorg Med Chem Lett; 2009 Feb; 19(3):860-2. PubMed ID: 19097785
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of potent antitumor and antiviral benzofuran derivatives.
Galal SA; Abd El-All AS; Abdallah MM; El-Diwani HI
Bioorg Med Chem Lett; 2009 May; 19(9):2420-8. PubMed ID: 19345581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
